Projects per year
Personal profile
Biography
Dr Kate Webber is a medical oncologist at Monash Health, where she serves as stream lead for gynaecological cancer clinical trials and holds an adjunct senior lecturer position at Monash University. She has subspecialty expertise in breast and gynaecological cancers, cancer survivorship and patient reported outcomes research. Dr Webber’s PhD and subsequent research has encompassed studies exploring the prevalence, predictors and trajectories of physical and psychological symptoms after cancer treatment, lifestyle and behavioural interventions, and novel models of delivery of survivorship care. Dr Webber is an active member of the Australia and New Zealand Gynaecological Oncology Group (ANZGOG) and has served as an investigator on over 30 gynaecological cancer clinical trials. Dr Webber is also passionate about supporting translation of clinical trial evidence into practice, and as such has served as the co-chair of the Cancer Institute NSW eviQ Medical Oncology Reference Committee from 2019-2023. Dr Webber is the deputy chair of the Clinical Oncology Society of Australia Survivorship Group and serves on its Patient Reported Outcomes Working Group. Her research team at Monash Health is currently exploring implementation of real time patient reported outcome measures into routine cancer care. She is also passionate about trainee education and currently oversees medical oncology advanced training at Monash Health.
Dr Webber graduated from the University of New South Wales in 2002 with first class honours and completed her specialty training in medical oncology at St George and Prince of Wales Hospitals in Sydney. She was then appointed the inaugural Survivorship Research Fellow at the National Centre for Cancer Survivorship at the University of New South Wales where she completed her PhD. Prior to her appointment at Monash Health, Dr Webber held staff specialist appointments in medical oncology at Prince of Wales Hospital and the Royal Hospital for Women in Sydney, as well as an honorary appointment at Sydney Children’s Hospital, and a conjoint lecturer position at UNSW. At Prince of Wales Hospital she also served as Clinical Superintendent for Medicine and co-Director of Advanced Physician Training, as well as convenor of the UNSW Human Research Ethics Advisory Panel (Biomedical).
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
PhD, University of New South Wales (UNSW)
Award Date: 21 Sept 2016
FRACP, Royal Australasian College of Physicians (RACP)
Award Date: 8 Dec 2010
B.Sc(Med) MBBS (honours class 1), University of New South Wales (UNSW)
Award Date: 13 Dec 2002
External positions
eviQ Medical Oncology Co-chair, Cancer Institute NSW (New South Wales)
30 Aug 2019 → …
Medical oncologist, Monash Health
3 Dec 2018 → …
Collaborations and top research areas from the last five years
-
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
Webber, K. (Primary Chief Investigator (PCI))
23/12/24 → 22/12/29
Project: Research
-
A Randomized Phase 2 Study of Ocular Toxicity Evaluation and Mitigation During Treatment with Mirvetuximab Soravtansine in Patients with Recurrent Ovarian Cancer with High Folate Receptor-Alpha Expression
Webber, K. (Primary Chief Investigator (PCI))
21/10/24 → 20/10/29
Project: Research
-
ENGOT-EN20/GOG-3083/XPORT-EC-042 Xport-EC-042 - A Phase 3, Randomized, placebo-controlled, double-blind, Multicenter trial of Selinexor in maintenance therapy after systemic therapy for patients with P53wild-type, advanced or recurrent endometrial carcinoma
Webber, K. (Primary Chief Investigator (PCI))
30/10/23 → 29/10/28
Project: Research
-
A Phase 3 Randomized, Open-label, Active-comparator Controlled Clinical Study of Pembrolizumab versus Platinum Doublet Chemotherapy in Participants With Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma in the First-line Setting (KEYNOTE-C93/GOG-3064/ENGOT-en15)
Frentzas, S. (Primary Chief Investigator (PCI)) & Webber, K. (Primary Chief Investigator (PCI))
21/03/22 → 15/03/27
Project: Research
-
PICCOLO: A Phase 2, Single Arm Study of Mirvetuximab Soravtansine in Recurrent Platinum-Sensitive, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression
Webber, K. (Primary Chief Investigator (PCI))
27/01/22 → 26/01/27
Project: Research
-
Health-related quality of life in rural cancer survivors compared with their urban counterparts: a systematic review
Latham, S., Leach, M. J., White, V. M., Webber, K., Jefford, M., Lisy, K., Davis, N., Millar, J. L., Evans, S., Emery, J. D., IJzerman, M. & Ristevski, E., Jul 2024, In: Supportive Care in Cancer. 32, 7, 17 p., 424.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access -
The effects of lifestyle and behavioural interventions on cancer recurrence, overall survival and quality of life in breast cancer survivors: A systematic review and network meta-analysis
Yeganeh, L., Willey, S., Wan, C. S., Bahri Khomami, M., Chehrazi, M., Cook, O. & Webber, K., Jul 2024, In: Maturitas. 185, 21 p., 107977.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access8 Citations (Scopus) -
Availability and accessibility of services to address financial toxicity described by Australian lung cancer patients and healthcare professionals
Chung, H., Hyatt, A., Kosmider, S., Webber, K. & Krishnasamy, M., Sept 2023, In: Supportive Care in Cancer. 31, 9, 8 p., 554.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Citations (Scopus) -
Factors Influencing COVID-19 Vaccine Hesitancy among Patients with Serious Chronic Illnesses during the Initial Australian Vaccine Rollout: A Multi-Centre Qualitative Analysis Using the Health Belief Model
Choi, T. S. T., Chan, B., Grech, L. B., Kwok, A., Webber, K., Wong, J. L. A., Nguyen, M., Bain, N., Day, D., McCartney, A., Hamer, R., Segelov, E. & on behalf of the CANVACCS, DIABVACCS and MSVACCS Investigators, Feb 2023, In: Vaccines. 11, 2, 17 p., 239.Research output: Contribution to journal › Article › Research › peer-review
Open Access4 Citations (Scopus) -
Relationship between survivorship care plans and unmet information needs, quality of life, satisfaction with care, and propensity to engage with, and attend, follow-up care
Hill, R. E., Mercieca-Bebber, R., Fardell, J. E., Wakefield, C. E., Signorelli, C., Webber, K. & Cohn, R. J., 1 Dec 2023, In: Cancer. 129, 23, p. 3820-3832 13 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access2 Citations (Scopus)
Prizes
-
-
-
The United Medical Protection Prize in Health Law and Ethics
Webber, K. (Recipient), 1999
Prize: Prize (including medals and awards)